Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany ; volume:22 ; number:1 ; day:15 ; month:4 ; year:2020 ; pages:1-11 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (15.4.2020), 1-11, 12.2020
- Creator
-
Heiligenhaus, Arnd
Klotsche, Jens
Niewerth, Martina
Horneff, Gerd
Ganser, Gerd
Haas, Johannes-Peter
Minden, Kirsten
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02166-3
- URN
-
urn:nbn:de:101:1-2020062815214177582438
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heiligenhaus, Arnd
- Klotsche, Jens
- Niewerth, Martina
- Horneff, Gerd
- Ganser, Gerd
- Haas, Johannes-Peter
- Minden, Kirsten
- SpringerLink (Online service)
Other Objects (12)
Juvenile idiopathic arthritis-associated uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Response to “Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany”
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Authors reply to the ‘Response to “Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany”’
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
P01-005 – Idiopathic uveitis and FMF
How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care
Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study
Juvenile idiopathic arthritis-associated uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Response to “Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany”
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Authors reply to the ‘Response to “Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany”’
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
P01-005 – Idiopathic uveitis and FMF
How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care
Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study
Juvenile idiopathic arthritis-associated uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Response to “Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany”
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Authors reply to the ‘Response to “Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany”’
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
P01-005 – Idiopathic uveitis and FMF
How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care